Evidence map›Paper›PMID 25668184›Full record

Trial reportPloS one2015

Plasma biomarker of dietary phytosterol intake.

Xiaobo Lin, Susan B Racette, Lina Ma, Michael Wallendorf, Catherine Anderson Spearie, Richard E Ostlund

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.7field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 23 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Xiaobo LinDivision of Endocrinology, Metabolism & Lipid Research, Department of Medicine, Institute for Clinical and Translational Sciences, Washington University School of Medicine, 660 South Euclid Ave., St. Louis, MO, 63110, United States of America.
Susan B RacetteDivision of Endocrinology, Metabolism & Lipid Research, Department of Medicine, Institute for Clinical and Translational Sciences, Washington University School of Medicine, 660 South Euclid Ave., St. Louis, MO, 63110, United States of America; Program in Physical Therapy, Institute for Clinical and Translational Sciences, Washington University School of Medicine, 660 South Euclid Ave., St. Louis, MO, 63110, United States of America.
Lina MaDivision of Endocrinology, Metabolism & Lipid Research, Department of Medicine, Institute for Clinical and Translational Sciences, Washington University School of Medicine, 660 South Euclid Ave., St. Louis, MO, 63110, United States of America.
Michael WallendorfDivision of Biostatistics, Institute for Clinical and Translational Sciences, Washington University School of Medicine, 660 South Euclid Ave., St. Louis, MO, 63110, United States of America.
Catherine Anderson SpearieLifestyle Intervention Research Core, Institute for Clinical and Translational Sciences, Washington University School of Medicine, 660 South Euclid Ave., St. Louis, MO, 63110, United States of America.
Richard E OstlundDivision of Endocrinology, Metabolism & Lipid Research, Department of Medicine, Institute for Clinical and Translational Sciences, Washington University School of Medicine, 660 South Euclid Ave., St. Louis, MO, 63110, United States of America.
Washington University in St. Louis · US

Funding

Washington University Institute of Clinical and Translational Sciences (UL1)UL1RR024992 · NCRR · WASHINGTON UNIVERSITY · PI EVANOFF, BRADLEY A · 2007 to 2011
$45.4M
Washington University Nutrition Obesity Research CenterP30DK056341 · NIDDK · WASHINGTON UNIVERSITY · PI Dominic N Reeds · 1999 to 2026
$30.2M
WU P&FP30DK020579 · NIDDK · WASHINGTON UNIVERSITY · PI Clay F. Semenkovich · 2013 to 2026
$27.1M
TRANSGENICS COREP60DK020579 · NIDDK · WASHINGTON UNIVERSITY · PI SCHAFFER, JEAN E. · 1986 to 2012
$25.2M
YOGA LIFESTYLE INTERVENTION REDUCES BLOOD PRESSURE IN HIV-INFECTED ADULTSP41RR000954 · NCRR · WASHINGTON UNIVERSITY · PI TAYLOR, JOHN-STEPHEN ADOLFINO · 1985 to 2011
$16.0M
REGULATION OF INTESTINAL CHOLESTEROL ABSORPTIONR01HL050420 · NHLBI · WASHINGTON UNIVERSITY · PI OSTLUND, RICHARD E. · 1994 to 2008
$4.0M
REVERSE CHOLESTEROL TRANSPORT IN HUMANSR01HL108160 · NHLBI · WASHINGTON UNIVERSITY · PI OSTLUND, RICHARD E. · 2012 to 2015
$2.1M
NCRR NIH HHS P41 RR000954NCRR NIH HHS RR-00954NCRR NIH HHS UL1 RR-024992NCRR NIH HHS UL1 RR024992NHLBI NIH HHS R01 HL050420NHLBI NIH HHS R01 HL108160NIDDK NIH HHS P30 DK020579NIDDK NIH HHS P30 DK056341NIDDK NIH HHS P60 DK020579NIDDK NIH HHS P60-DK20579PHS HHS R01-108160PHS HHS R01-50420
6 · The paper itself

Abstract

backgroundDietary phytosterols, plant sterols structurally similar to cholesterol, reduce intestinal cholesterol absorption and have many other potentially beneficial biological effects in humans. Due to limited information on phytosterol levels in foods, however, it is difficult to quantify habitual dietary phytosterol intake (DPI). Therefore, we sought to identify a plasma biomarker of DPI. METHODS AND

findingsData were analyzed from two feeding studies with a total of 38 subjects during 94 dietary periods. DPI was carefully controlled at low, intermediate, and high levels. Plasma levels of phytosterols and cholesterol metabolites were assessed at the end of each diet period. Based on simple ordinary least squares regression analysis, the best biomarker for DPI was the ratio of plasma campesterol to the endogenous cholesterol metabolite 5-α-cholestanol (R2 = 0.785, P < 0.0001). Plasma campesterol and 5-α-cholestanol levels varied greatly among subjects at the same DPI level, but were positively correlated at each DPI level in both studies (r > 0.600; P < 0.01).

conclusionThe ratio of plasma campesterol to the coordinately regulated endogenous cholesterol metabolite 5-α-cholestanol is a biomarker of dietary phytosterol intake. Conversely, plasma phytosterol levels alone are not ideal biomarkers of DPI because they are confounded by large inter-individual variation in absorption and turnover of non-cholesterol sterols. Further work is needed to assess the relation between non-cholesterol sterol metabolism and associated cholesterol transport in the genesis of coronary heart disease.

Indexed as

AdolescentAdultAgedAged, 80 and overBiomarkersCholestanolCholesterolDietFemaleHumansMaleMiddle AgedPhytosterolsYoung AdultBiomarkerscampesterolCholestanolCholesterolPhytosterols

Identifiers

PMID25668184
PMCPMC4323197
OpenAlexW2042785984

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.